Further characterization of these cells showed that the increased IL-22 frequency in the tumor was owing to an enrichment of IL-17A+IL-22+ double producing CD4+ T cells, whereas IL-17A-L-22+ single producing T cells were not changed (Fig. 1B–D). The gene discussed is IL17A; the disease is neoplasm.